Skip to content
December 21, 2025
  • Netflix’s $72 billion Warner Bros deal faces skepticism over YouTube rivalry claim
  • Exxon boosts forecast, aims for $25 billion earnings growth by 2030
  • Trump to issue order creating national AI rule
  • ‘Big Short’ investor Burry targets Tesla after slamming AI valuations
The Cheap Investor

The Cheap Investor

Random News
  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters

AP

  • AP
  • Headlines

BioNTech reports strong first half, expects demand to grow

The Cheap Investor3 years ago3 years ago02 mins

BERLIN (AP) — BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported higher revenue and net profit in the first half of the year and expects demand to grow as it releases updated vaccines to target new omicron strains. The German pharmaceutical company said Monday that revenue hit about 9.57 billion…

Read More
  • AP
  • Headlines

Nonprofits launch $100M plan to support local health workers

The Cheap Investor3 years ago3 years ago06 mins

A new philanthropic project hopes to invest $100 million in 10 countries, mostly in Africa, by 2030 to support 200,000 community health workers, who serve as a critical bridge to treatment for people with limited access to medical care. The Skoll Foundation and The Johnson & Johnson Foundation announced Monday that they donated a total…

Read More
  • AP
  • Headlines

Hungary fines Ryanair over raising prices to cope with tax

The Cheap Investor3 years ago3 years ago02 mins

BUDAPEST, Hungary (AP) — Hungary accused Ryanair of consumer protection violations and fined it more than three-quarters of a million euros after the budget carrier raised ticket prices to cope with a tax on what the government calls “extra profits” of industries ranging from airlines to banks. Justice Minister Judit Varga wrote Monday on Facebook…

Read More
  • AP
  • Headlines

Pfizer buying spree continues with $5.4B hematology deal

The Cheap Investor3 years ago3 years ago03 mins

Pfizer will spend about $5.4 billion to buy Global Blood Therapeutics as the pharmaceutical giant continues to invest some of the cash influx reaped during the COVID-19 pandemic. Pfizer said Monday that the acquisition will boost its work in rare hematology. Global Therapeutics, which was founded in 2011, makes Oxybryta tablets for treating sickle cell…

Read More
  • AP
  • Headlines

Russia, Ukraine trade accusations over nuclear plant attacks

The Cheap Investor3 years ago3 years ago06 mins

KYIV, Ukraine (AP) — Russia and Ukraine traded accusations Monday that each side is shelling Europe’s biggest nuclear power plant in southern Ukraine. Russia claimed that Ukrainian shelling caused a power surge and fire and forced staff to lower output from two reactors, while Ukraine has blamed Russian troops for storing weapons there. Nuclear experts…

Read More
  • AP
  • Headlines

Japan tech giant SoftBank posts $23 billion quarterly loss

The Cheap Investor3 years ago3 years ago03 mins

TOKYO (AP) — Japanese technology company SoftBank Group posted a $23.4 billion loss in the April-June quarter as the value of its investments sank amid global worries about inflation and interest rates. SoftBank Group Corp.’s loss of 3.16 trillion yen was a reversal from its 762 billion yen profit in the same quarter a year…

Read More
  • AP
  • Headlines

Water crisis looms for eastern Ukrainian city of Sloviansk

The Cheap Investor3 years ago3 years ago05 mins

SLOVIANSK, Ukraine (AP) — The echo of artillery shells thundering in the distance mingles with the din of people gathered around Sloviansk’s public water pumps, piercing the uneasy quiet that smothers the nearly deserted streets of this eastern Ukrainian city. The members of Sloviansk’s dwindling population only emerge — a few minutes at a time…

Read More
  • AP
  • Headlines

Asian shares mostly decline on global technology downturn

The Cheap Investor3 years ago3 years ago04 mins

TOKYO (AP) — Asian shares mostly declined Tuesday amid a global fall in technology shares, including Japan’s SoftBank, which has reported hefty losses caused by the market downturn. Such worries are coming on top of concerns about inflation and what central banks might do to curb that trend. Higher interest rates tend to work as…

Read More
  • AP
  • Headlines

Asian stocks mixed after US job gain paves way for rate hike

The Cheap Investor3 years ago3 years ago03 mins

BEIJING (AP) — Asian stocks were mixed on Monday after strong U.S. jobs data cleared the way for more interest rate hikes and China reported its exports rose by double digits. Shanghai and Tokyo advanced while Hong Kong and Seoul retreated. Oil prices edged higher. Wall Street’s benchmark S&P 500 lost 0.2% on Friday after…

Read More
  • AP
  • Headlines

China July exports rise, with trade surplus at record-high

The Cheap Investor3 years ago3 years ago01 mins

BEIJING (AP) — China’s export growth continued to rise in July, sending trade surplus to a record high, according to government data. China’s exports grew 18% to $333 billion compared to the same period last year, and were up from 17.9% in June, according to data from China’s customs. Imports, however, remained soft, growing 2.3%…

Read More
  • 1
  • …
  • 137
  • 138
  • 139
  • 140
  • 141
  • …
  • 357

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Recent Posts

  • Netflix’s $72 billion Warner Bros deal faces skepticism over YouTube rivalry claim
  • Exxon boosts forecast, aims for $25 billion earnings growth by 2030
  • Trump to issue order creating national AI rule
  • ‘Big Short’ investor Burry targets Tesla after slamming AI valuations
  • Blue Origin unveils plan for bigger New Glenn rocket variant to take on SpaceX
  • Elliott builds stake in Barrick Mining, source says
  • US airlines cut hundreds of flights Friday after FAA shutdown directive
  • Trump administration to pay reduced food aid benefits using emergency funds
Copyright 2025 © All rights reserved | The Cheap Investor | thecheapinvestor.com
  • Home
  • Disclaimer
  • Contact Us
  • Terms of Service
  • Privacy Policy